Biofrontera (BFRIW) Expected to Post Quarterly Earnings on Wednesday

Biofrontera (NASDAQ:BFRIW) will likely be releasing its results before the market opens on Wednesday, November 18th. Analysts expect Biofrontera to announce earnings of ($0.22) per share and revenue of $8.25 million for the quarter.

Biofrontera Stock Performance

BFRIW stock opened at $0.00 on Wednesday. Biofrontera has a 1 year low of $0.00 and a 1 year high of $0.15. The stock’s fifty day moving average is $0.01 and its two-hundred day moving average is $0.03.

Biofrontera Company Profile

Biofrontera Inc. is a biopharmaceutical company focused on dermatology. It develops and commercializes treatments for sun-damaged skin and other conditions, with an emphasis on photodynamic therapy, which uses a light-sensitive medicine activated by a light source. Biofrontera Inc. became a separately traded U.S. company after its separation from Germany-based Biofrontera AG. BFRIW represents warrants associated with Biofrontera Inc., rather than the company’s common stock.